ISCO - Innovations in Single Cell Omics
ISCO conference for single cell researchers from diferent disciplines, co-organized by leading centres for genomic and biomedical research in Berlin and Barcelona.
ISCO conference for single cell researchers from diferent disciplines, co-organized by leading centres for genomic and biomedical research in Berlin and Barcelona.
Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Twice a year, the start-up competition Gründungswettbewerb – Digitale Innovationen by the Federal Ministry for Economic Affairs and Climate Protection's (BMWK) honors the best ideas of innovative start-ups that are based on digital technologies. The award supports start-ups in the early stages and emphasizes their key role as drivers of innovation…
On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…
An interdisciplinary team led by Prof. Angela Relógio, a scientist at Charité’s Molecular Cancer Research Center (MKFZ) and Institute for Theoretical Biology and the MSH Medical School Hamburg, has developed a non-invasive method for profiling a person’s unique circadian rhythm. Starting with a simple saliva sample, the team of experts can create a…
The Haas group develops and applies novel multimodal single-cell and spatially-resolved technologies to study the complex etiology of hematological cancers and their interaction with the immune system.
Hematopoiesis describes the process of blood formation and is sustained by the activity of hematopoietic stem and progenitor cells throughout our lifetime. While our understanding of stem cell biology continues to grow, it still remains challenging to study the in vivo activity of individual stem cells in humans.
On January 24 in Berlin, four innovation teams from the Digital Health Accelerator pilot project of Berlin Institute of Health (BIH) and two start-ups from Charité – Universitätsmedizin Berlin presented their digital health solutions for everyday clinical use. The new solutions leverage in particular imaging and big data big data analytical…